Anti-Biofilm Perspectives of Propolis against Staphylococcus epidermidis Infections
- PMID: 39062493
- PMCID: PMC11274400
- DOI: 10.3390/biom14070779
Anti-Biofilm Perspectives of Propolis against Staphylococcus epidermidis Infections
Abstract
Staphylococcus epidermis has emerged as the main causative agent of medical device-related infections. Their major pathogenicity factor lies in its ability to adhere to surfaces and proliferate into biofilms, which increase their resistance to antibiotics. The main objective of this study was to evaluate the use and the mechanism of action of an ethanolic extract of Spanish propolis (EESP) as a potential alternative for preventing biofilm-related infections caused by S. epidermidis. The chemical composition of propolis is reported and its antibacterial activity against several strains of S. epidermidis with different biofilm-forming capacities evaluated. The influence of sub-inhibitory concentrations (sub-MICs) of EESP on their growth, physicochemical surface properties, adherence, and biofilm formation were studied. EESP interferes with planktonic cells, homogenizing their physicochemical surface properties and introducing a significant delay in their growth. The adherence and biofilms at the EESP concentrations investigated were decreased up to 90.5% among the strains. Microscopic analysis indicated that the planktonic cells that survived the treatment were the ones that adhere and proliferate on the surfaces. The results obtained suggest that the EESP has a high potential to be used as an inhibitor of both the adhesion and biofilm formation of S. epidermidis.
Keywords: Staphylococcus epidermidis; biofilms; hydrophobicity; propolis; zeta potential.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Cationic chitosan-propolis nanoparticles alter the zeta potential of S. epidermidis, inhibit biofilm formation by modulating gene expression and exhibit synergism with antibiotics.PLoS One. 2019 Feb 28;14(2):e0213079. doi: 10.1371/journal.pone.0213079. eCollection 2019. PLoS One. 2019. PMID: 30818374 Free PMC article.
-
Biofilm formation is not necessary for development of quinolone-resistant "persister" cells in an attached Staphylococcus epidermidis population.Int J Artif Organs. 2008 Sep;31(9):752-60. doi: 10.1177/039139880803100902. Int J Artif Organs. 2008. PMID: 18924086
-
Dual-function antimicrobial-antibiofilm peptide hybrid to tackle biofilm-forming Staphylococcus epidermidis.Ann Clin Microbiol Antimicrob. 2024 May 16;23(1):44. doi: 10.1186/s12941-024-00701-7. Ann Clin Microbiol Antimicrob. 2024. PMID: 38755634 Free PMC article.
-
Antibiofilm activity of three Actinomycete strains against Staphylococcus epidermidis.Lett Appl Microbiol. 2019 Jan;68(1):73-80. doi: 10.1111/lam.13087. Epub 2018 Nov 22. Lett Appl Microbiol. 2019. PMID: 30338533 Review.
-
Staphylococcus epidermidis biofilm in inflammatory breast cancer and its treatment strategies.Biofilm. 2024 Sep 13;8:100220. doi: 10.1016/j.bioflm.2024.100220. eCollection 2024 Dec. Biofilm. 2024. PMID: 39318870 Free PMC article. Review.
Cited by
-
The Comparative Study of the Antioxidant and Antibacterial Effects of Propolis Extracts in Veterinary Medicine.Vet Sci. 2024 Aug 15;11(8):375. doi: 10.3390/vetsci11080375. Vet Sci. 2024. PMID: 39195829 Free PMC article.
-
Anatolian propolis extracts enhance cisplatin efficacy in ovarian cancer through AKT/mTOR pathway modulation and demonstrate antibacterial and antibiofilm activities.Med Oncol. 2025 Jul 11;42(8):323. doi: 10.1007/s12032-025-02888-x. Med Oncol. 2025. PMID: 40643738
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases